** Shares of heart company Anteris Technologies slide 12.3% to $5.26 in their Nasdaq debut
** Stock opened for trading at $6, valuing the company at $215.6 mln
** AVR sold 14.8 mln shares in its New York IPO at $6/shr to raise $88.8 mln
** Offering priced at a 11.5% discount to the Dec. 5 closing price of its shares on the Australian Securities Exchange
** TD Cowen, Barclays and Cantor were the joint book-running managers for the offering
** AVR will use the proceeds to fund the development of its transcatheter heart valve, among other purposes
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。